Advertisement
Table 3 Basic characteristics of participants in stage-2 study
| HC | NA | MA | OA | |
|---|---|---|---|---|
| Number | 20 | 20 | 20 | 20 |
| Age | 49.7 ± 7.5 | 50.6 ± 15.3 | 50.1 ± 13.7 | 55.7 ± 14.0 |
| Gender (male/female) | 13/7 | 11/9 | 13/7 | 14/6 |
| eGFR (ml/min/1.73 m2) | 102.6 [95.0–114.6] | 102.6 [77.1–115.0] | 88.5 [79.2–138.8] | 82.9 [32.8–123.8]* |
| ACR (mg/g) | 10.1 [4.7–15.1] | 12.0 [5.9–20.5] | 78.4 [58.8–149.3]* | 1503.0 [619.9–3743.0]* |
| Glu (mmol/L) | 4.9 [4.3–5.2] | 8.6 [7.0–11.1]* | 10.1 [7.5–12.7]* | 12.3 [7.5–15.0]* |
| HbA1c (%) | 4.9 [4.7–5.2] | 8.3 [7.0–10.2]* | 8.5 [6.8–9.3]* | 9.1 [8.2–11.1]* |
| SBP (mmHg) | 116.5 ± 9.5 | 123.2 ± 10.6 | 135.4 ± 12.3* | 145.5 ± 18.6* |
| DBP (mmHg) | 74.3 ± 5.8 | 80.2 ± 7.3 | 82.5 ± 10.1* | 85.5 ± 7.8* |
| Urinary NAG/Cr (U/mol) | 0.48 ± 0.14 | 0.69 ± 0.27 | 1.17 ± 0.44* | 1.93 ± 0.53* |
